title: High plasma neurotensin levels in children with Prader-Willi syndrome.
abstract: Prader-Willi syndrome (PWS) is an obesity-related genetic condition, most commonly due to a paternal deletion of the chromosome 15q11-q13 region. PWS is characterized by growth hormone deficiency, infantile hypotonia and feeding problems, hypogenitalism/hypogonadism, increased pain threshold and thermal instability, decreased gastric motility, and hyperphagia in childhood leading to severe obesity. Neuro-endocrine peptides are known to influence gastric function and pain sensation which led us to measure a specific peptide that may be involved [i.e., neurotensin (NT)] in PWS and compared with unrelated control siblings. Overnight fasting plasma NT levels were obtained from 23 children with confirmed PWS (age: 8.2 ± 2.0 years; range: 5-11 years) and 18 unaffected, unrelated siblings (age: 8.2 ± 2.3 years; range: 5-11 years) and measured using Multiplex sandwich immunoassays with the Luminex magnetic-bead based platform. Plasma NT levels were natural log-transformed and analyzed by ANOVA with adjustments for age, gender, and body mass index (BMI). No difference was found in plasma NT levels for gender, age or BMI or significant correlations seen with age or BMI. Higher plasma NT levels (P < 0.001) were seen in PWS children (mean of 626 ± 238 pg/ml) compared with unaffected, unrelated siblings (mean of 371 ± 236 pg/ml). Plasma levels were also higher in children with maternal disomy 15 (736 ± 182 pg/ml) compared with those having the deletion subtype (548 ± 247 pg/ml, P < 0.04). Although no measures for pain threshold, thermal instability or gastric motility were performed in our study participants, higher plasma NT levels were found in PWS children.
authors.affiliation: Departments of Psychiatry & Behavioral Sciences and Pediatrics, University of Kansas Medical Center, Kansas City, Kansas.
authors.forename: Merlin G
authors.initials: MG
authors.lastname: Butler
authors.affiliation: Departments of Psychiatry & Behavioral Sciences and Pediatrics, University of Kansas Medical Center, Kansas City, Kansas.
authors.forename: Tommy A
authors.initials: TA
authors.lastname: Nelson
authors.affiliation: Department of Pediatrics and Center for Epigenetics, University of Florida Medical Center, Gainesville, Florida.
authors.forename: Daniel J
authors.initials: DJ
authors.lastname: Driscoll
authors.affiliation: Departments of Psychiatry & Behavioral Sciences and Pediatrics, University of Kansas Medical Center, Kansas City, Kansas.
authors.forename: Ann M
authors.initials: AM
authors.lastname: Manzardo
mesh_terms: D016022:Case-Control Studies; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D008297:Male; D009496:Neurotensin / Q000097:blood*; D011218:Prader-Willi Syndrome / Q000097:blood*
chemical_list: D009496:Neurotensin
keywords: Prader-Willi syndrome; analgesia; gastric motility; neurotensin; plasma; thermal instability
references.citation: Trends Pharmacol Sci. 1999 Jul;20(7):302-9
references.pmid: 10390649
references.citation: Eur J Pharmacol. 1999 Sep 17;381(1):9-12
references.pmid: 10528128
references.citation: Pediatr Neurol. 2002 Feb;26(2):130-3
references.pmid: 11897477
references.citation: J Comp Neurol. 2003 Jul 7;461(4):520-38
references.pmid: 12746866
references.citation: Neuroscience. 1992 Sep;50(2):259-68
references.pmid: 1436492
references.citation: Pain. 2005 Mar;114(1-2):285-94
references.pmid: 15733655
references.citation: Expert Rev Mol Med. 2005 Jul 25;7(14):1-20
references.pmid: 16038620
references.citation: J Neurosci. 2005 Sep 7;25(36):8188-96
references.pmid: 16148226
references.citation: Obesity (Silver Spring). 2006 Jun;14(6):1028-37
references.pmid: 16861608
references.citation: Nat Clin Pract Endocrinol Metab. 2006 Nov;2(11):592-3
references.pmid: 17082801
references.citation: J Pediatr Gastroenterol Nutr. 2007 Aug;45(2):272-4
references.pmid: 17667731
references.citation: Am J Med Genet A. 2008 Mar 1;146A(5):665-9
references.pmid: 18241068
references.citation: Int J Immunopathol Pharmacol. 2008 Apr-Jun;21(2):255-9
references.pmid: 18547468
references.citation: Am J Med Genet A. 2009 Feb;149A(2):138-9
references.pmid: 19133690
references.citation: Curr Opin Endocrinol Diabetes Obes. 2011 Feb;18(1):75-82
references.pmid: 21124211
references.citation: Am J Med Genet A. 2011 May;155A(5):1040-9
references.pmid: 21465655
references.citation: Regul Pept. 2011 Oct 10;170(1-3):7-17
references.pmid: 21549161
references.citation: Curr Genomics. 2011 May;12(3):204-15
references.pmid: 22043168
references.citation: Int J Dev Neurosci. 2012 Apr;30(2):121-7
references.pmid: 22197967
references.citation: Genet Med. 2012 Jan;14(1):10-26
references.pmid: 22237428
references.citation: Am J Med Genet. 1990 Mar;35(3):319-32
references.pmid: 2309779
references.citation: Eur J Pharmacol. 2013 Sep 15;716(1-3):54-60
references.pmid: 23500196
references.citation: Am J Med Genet A. 2015 Mar;167A(3):563-71
references.pmid: 25691409
references.citation: Neuroscience. 1987 Aug;22(2):499-524
references.pmid: 3670596
references.citation: Eur J Pharmacol. 1979 Feb 15;54(1-2):129-39
references.pmid: 421735
references.citation: Acta Physiol Scand. 1979 Nov;107(3):263-67
references.pmid: 539456
references.citation: Lancet. 1980 May 10;1(8176):987-9
references.pmid: 6103384
references.citation: Eur J Pharmacol. 1982 Jul 16;81(3):499-503
references.pmid: 6811292
references.citation: Acta Physiol Scand. 1978 Oct;104(2):244-6
references.pmid: 716977
references.citation: Br J Pharmacol. 1994 Jun;112(2):352-4
references.pmid: 8075852
references.citation: Genomics. 1996 Dec 1;38(2):243-5
references.pmid: 8954810
references.citation: J Pharmacol Exp Ther. 1997 Aug;282(2):899-908
references.pmid: 9262357
references.citation: Am J Med Genet. 1997 Dec 31;73(4):437-41
references.pmid: 9415471